PEPTIDE RESEARCH TOPIC

DSIP Research Peptide

Explore DSIP research, delta sleep-inducing peptide identity, historical sleep studies, experimental findings, evidence limitations, and safety context.

TOPIC OVERVIEW

About DSIP

Identity and names

DSIP expands to delta sleep-inducing peptide and is also associated with the name emideltide. The name describes a research history rather than a proven sleep benefit.

Compound type

DSIP is a short peptide studied in neurophysiology. Preparation, route, and experimental conditions are important when comparing studies.

Mechanism

Research addresses sleep-wake regulation and related physiological responses. Its mechanism and effects cannot be summarized as a universally reliable sleep switch.

Research focus and evidence

Historical human studies were small and used defined laboratory conditions. Contemporary consumer claims can exceed what those studies establish.

Regulatory status and limits

Historical clinical experiments do not amount to approval of research-market DSIP. Human safety, preparation quality, and route-specific evidence need assessment.

Topics covered
  • sleep-wake research
  • historical human trials
  • mechanistic uncertainty
  • preparation and safety
Common names and related terms: DSIP, Delta sleep-inducing peptide, Emideltide
RESEARCH SUMMARY

What Is DSIP?

LAST VERIFIEDOctober 7, 2026

A placebo-controlled, double-blind study evaluated DSIP in 14 people with severe chronic insomnia over a short treatment period. Its size and duration limit conclusions about routine or long-term use. Schneider-Helmert, chronic-insomnia study

An earlier open study in seven patients investigated repeated DSIP administration. Without a blinded comparison, reported changes cannot by themselves establish a dependable treatment effect. Historical open DSIP clinical study

EVIDENCE PROFILE

DSIP Research Evidence

A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.

LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records451
Compound typeDSIP is a short peptide studied in neurophysiology. Preparation, route, and experimental conditions are important when comparing studies.
AliasesDSIP, Delta sleep-inducing peptide, Emideltide
Evidence stageHistorical human studies were small and used defined laboratory conditions. Contemporary consumer claims can exceed what those studies establish.
U.S. regulatory contextHistorical clinical experiments do not amount to approval of research-market DSIP. Human safety, preparation quality, and route-specific evidence need assessment.
CLINICAL REGISTRY

Selected registered research

No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.

INDEXED LITERATURE

Selected PubMed records

PMID 36225821987 · European neurology

Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.

PMID 63919261984 · European neurology

A clinical trial with DSIP.

PMID 114378702001 Jul · European journal of anaesthesiology

Delta sleep-inducing peptide.

How to interpret this profile

Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.

Primary sources: ClinicalTrials.gov (defined search) · PubMed (defined query)Checked October 7, 2026. Counts include interventional registry records with an explicit matching intervention name or alias; broad search results, biomarker-only observations, and unrelated compounds are excluded. Active includes recruiting, not yet recruiting, active not recruiting, and enrolling by invitation. PubMed is the linked title/abstract query count, not a number of clinical trials or a measure of evidence quality.

Displayed records are selected for relevance and recency; the page does not reproduce the complete source databases.

START HERE

Essential DSIP guides

DSIP KNOWLEDGE ARTICLESPage 1 of 9
01
KNOWLEDGE ARTICLE

DSIP Peptide: Benefits and Side Effects Explained

DSIP peptide benefits and side effects explained: how delta sleep-inducing peptide works, research findings, safety concerns, and what to know before using it.

↗
04
KNOWLEDGE ARTICLE

Is DSIP FDA-Approved? What US Buyers Should Know

Is DSIP FDA-approved? No. DSIP is sold as a research chemical with no FDA approval for human use. Here's what US buyers should know about safety and law.

↗
06
KNOWLEDGE ARTICLE

DSIP Risks: Side Effects, Safety & What to Know

DSIP risks include injection site reactions, daytime drowsiness, and unknown long-term effects. DSIP is not FDA-approved, and dosing is unregulated.

↗
08
KNOWLEDGE ARTICLE

Phospho DSIP: Research, Dosage, and Safety Guide

Phospho DSIP is a phosphorylated delta sleep-inducing peptide studied for sleep and stress. Learn what research shows, typical dosing ranges, and safety.

↗
09
KNOWLEDGE ARTICLE

DSIP Dosage Reddit: What Users Actually Report

Curious about DSIP dosage Reddit discussions? See typical ranges users mention, how to calculate doses, nasal spray and cycle tips, plus safety notes.

↗
13
KNOWLEDGE ARTICLE

DSIP Injection: What It Is, Dosage, and Safety

A DSIP injection delivers delta sleep-inducing peptide, a research-only compound studied for sleep. Learn reported dosage ranges, reconstitution, and safety.

↗
16
KNOWLEDGE ARTICLE

Does DSIP Make You Sleepy? What Research Shows

Wondering does DSIP make you sleepy? Learn how delta sleep-inducing peptide affects drowsiness, what research says, and how it compares to other peptides.

↗
18
KNOWLEDGE ARTICLE

DSIP 5 mg: Dosage, Effects, and Research Overview

DSIP 5 mg is a research-grade vial of delta sleep-inducing peptide. Learn typical dosing ranges, nasal spray use, side effects, and what studies actually show.

↗
20
KNOWLEDGE ARTICLE

DSIP Transport Canada: Shipping Rules & Safety

DSIP transport Canada rules explained: Health Canada status, customs seizure risk, cold-chain handling, and safer domestic options for research peptides.

↗